High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$200M
$200,728,646
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-23 | $1,104,000Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-23 | $2,391,318Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-23 | $739,642 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-23 | $4,426,181Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-17 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-17 | $3,785,935Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-17 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-17 | $7,031,021Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-09 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-09 | $3,737,890Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-09 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-09 | $6,941,796Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-02 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-02 | $3,708,750Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-02-02 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-02-02 | $6,887,679Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-26 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-26 | $3,716,276Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-26 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-26 | $6,901,656Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $321,116 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $316,879 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $52,996 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-20 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $6,591 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -85.7%
|
2026-01-20 | $39,511 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -82.2%
|
2026-01-20 | $211,600 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.9%
|
2026-01-20 | $264,724 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.6%
|
2026-01-20 | $568,468 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.3%
|
2026-01-20 | $612,430 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $124,963 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $123,244 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $172,944 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $170,345 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $28,783 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-20 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $12,240 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -85.7%
|
2026-01-20 | $73,378 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -82.1%
|
2026-01-20 | $392,704 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -74.1%
2026-01-20
$1,367,836Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -74.1%
|
2026-01-20 | $1,367,836Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.1%
|
2026-01-20 | $278,386 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.9%
|
2026-01-20 | $491,697 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -24.3%
|
2026-01-20 | $834,407 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -23.5%
2026-01-20
$1,055,264Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.5%
|
2026-01-20 | $1,055,264Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -20.3%
2026-01-20
$1,137,768Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.3%
|
2026-01-20 | $1,137,768Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $231,943 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-20 | $229,013 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -74.1%
|
2026-01-20 | $736,347 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.1%
|
2026-01-20 | $149,936 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -24.3%
|
2026-01-20 | $449,296 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-12 | $3,776,107Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-12 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2026-01-12 | $7,012,769Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2026-01-12 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-15 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $127,707 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.2%
|
2025-12-15 | $721,733 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -20.1%
2025-12-15
$1,280,472Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.1%
|
2025-12-15 | $1,280,472Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -14.0%
|
2025-12-15 | $714,518 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -19.2%
|
2025-12-15 | $714,207 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -15.1%
|
2025-12-15 | $664,359 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $258,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -22.0%
|
2025-12-15 | $608,829 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.8%
|
2025-12-15 | $298,746 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $1,869,140Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-15 | $3,768,800Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $68,765 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.2%
|
2025-12-15 | $388,436 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -20.1%
|
2025-12-15 | $689,560 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -14.0%
|
2025-12-15 | $384,930 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -16.3%
|
2025-12-15 | $384,840 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.0%
|
2025-12-15 | $357,236 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $139,278 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -22.0%
|
2025-12-15 | $327,831 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.8%
|
2025-12-15 | $160,863 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-15 | $1,006,614Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.5%
|
2025-12-01 | $509,005 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.2%
|
2025-12-01 | $757,272 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -46.8%
2025-12-01
$1,174,035Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -46.8%
|
2025-12-01 | $1,174,035Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-01 | $60,911 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-01 | $87,850 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.6%
|
2025-12-01 | $438,767 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -28.8%
|
2025-12-01 | $751,488 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -46.8%
2025-12-01
$2,180,624Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -46.8%
|
2025-12-01 | $2,180,624Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -23.2%
2025-12-01
$1,405,815Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -23.2%
|
2025-12-01 | $1,405,815Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.5%
|
2025-12-01 | $945,363 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-01 | $1,722,240Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -56.2%
2025-12-01
$1,396,240Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -56.2%
|
2025-12-01 | $1,396,240Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -74.7%
|
2025-12-01 | $814,440 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.1%
|
2025-12-01 | $163,150 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-12-01 | $113,120 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-12-01 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-24 | $1,625,040Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-24 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-24 | $3,730,048Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-24 | $309,120 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-24 | $1,243,349Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-24 | $5,683,883Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-17 | $6,880,091Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-17 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-17 | $3,704,665Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-17 | $766,658 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-17 | $383,329 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-10 | $6,611,870Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-10 | $3,559,813Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-10 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-10 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-03 | $416,976 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -19.7%
2025-11-03
$1,164,868Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -19.7%
|
2025-11-03 | $1,164,868Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -26.6%
2025-11-03
$1,268,407Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -26.6%
|
2025-11-03 | $1,268,407Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -39.8%
2025-11-03
$1,395,391Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -39.8%
|
2025-11-03 | $1,395,391Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -43.7%
|
2025-11-03 | $925,707 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -32.6%
|
2025-11-03 | $389,551 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -31.8%
|
2025-11-03 | $256,427 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -45.8%
|
2025-11-03 | $252,627 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -75.0%
|
2025-11-03 | $225,204 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-03 | $75,131 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-03 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-11-03 | $3,287,785Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-11-03 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-27 | $255,552 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-27 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-27 | $6,105,886Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-27 | $894,434 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -98.4%
2025-10-27
$3,287,785Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -98.4%
|
2025-10-27 | $3,287,785Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-20 | $6,250,857Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-20 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-20 | $3,365,846Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-20 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-13 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-13 | $6,440,176Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-13 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-13 | $3,467,787Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -93.6%
2025-10-06
$2,994,745Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -93.6%
|
2025-10-06 | $2,994,745Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-06 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $179,928 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $360,777 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -89.2%
2025-10-06
$5,413,011Whale
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -89.2%
|
2025-10-06 | $5,413,011Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -86.2%
|
2025-10-06 | $566,449 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $50,795 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-10-06 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $135,017 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $225,507 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -77.8%
|
2025-10-06 | $158,728 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-10-06 | $45,481 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-29 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -30.4%
|
2025-09-29 | $603,947 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.4%
|
2025-09-29 | $447,043 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -11.0%
|
2025-09-29 | $300,136 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $155,374 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $277,650 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $145,809 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-29 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $27,999 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.6%
|
2025-09-29 | $41,232 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -75.2%
|
2025-09-29 | $209,603 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -43.0%
|
2025-09-29 | $208,662 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -37.2%
|
2025-09-29 | $286,316 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -54.9%
|
2025-09-29 | $935,187 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -34.0%
|
2025-09-29 | $876,292 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -30.4%
2025-09-29
$1,121,434Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -30.4%
|
2025-09-29 | $1,121,434Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -18.4%
|
2025-09-29 | $829,680 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -11.0%
|
2025-09-29 | $557,036 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $288,970 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $515,635 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $270,787 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-29 | $15,076 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.3%
|
2025-09-29 | $21,905 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -73.3%
|
2025-09-29 | $113,160 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -42.3%
|
2025-09-29 | $112,422 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -37.1%
|
2025-09-29 | $154,203 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -54.9%
|
2025-09-29 | $503,203 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -34.0%
|
2025-09-29 | $471,752 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-22 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-22 | $6,089,170Whale | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-22 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-22 | $3,278,784Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -39.9%
|
2025-09-15 | $268,618 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -55.3%
|
2025-09-15 | $828,975 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -38.0%
|
2025-09-15 | $916,148 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -13.2%
|
2025-09-15 | $367,259 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.6%
|
2025-09-15 | $326,325 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $41,671 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-15 | $1,149,986Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $826,965 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -41.7%
|
2025-09-15 | $591,035 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -59.2%
2025-09-15
$2,045,227Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -59.2%
|
2025-09-15 | $2,045,227Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
BENKOWITZ MICHAEL
• COO
10b5-1 SellΔOwn -25.2%
2025-09-15
$1,164,254Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -25.2%
|
2025-09-15 | $1,164,254Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 SellΔOwn -10.9%
|
2025-09-15 | $564,689 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $549,268 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $117,101 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
Other
|
2025-09-15 | $1,980,517Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
COO
10b5-1 Sell
|
2025-09-15 | $405,091 | S | Form 4 |